Atara Biotherapeutics Inc
F:AT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atara Biotherapeutics Inc
F:AT2
|
US |
|
C
|
Central Garden & Pet Co
F:GP7
|
US |
|
SoFi Technologies Inc
F:6B0
|
US |
|
G
|
Golub Capital Bdc Inc
F:OGL
|
US |
|
I
|
Ipsen SA
OTC:IPSEF
|
FR |
|
G
|
Grupo Aeroportuario del Sureste SAB de CV
SWB:AED
|
MX |
|
F
|
Ford Motor Co
XMUN:FMC1
|
US |
|
H
|
Honeywell International Inc
XHAM:ALD
|
US |
|
I
|
IMCD NV
F:INX
|
NL |
|
S
|
SugarBud Craft Growers Corp
F:REL
|
CA |
|
E
|
Elisa Oyj
F:EIA
|
FI |
|
U
|
United Parcel Service Inc
BMV:UPS
|
US |
|
H
|
Harley-Davidson Inc
XMUN:HAR
|
US |
|
E
|
EBOS Group Ltd
F:EJG
|
AU |
|
Flex Ltd
NASDAQ:FLEX
|
SG |
|
G
|
GFPT PCL
SET:GFPT
|
TH |
|
Arctic Paper SA
F:A0P
|
PL |
|
W
|
Waters Corp
XMUN:WAZ
|
US |
Wall St Price Targets
AT2 Price Targets Summary
Atara Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for AT2 is 8.87 EUR with a low forecast of 3.76 EUR and a high forecast of 17.61 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AT2's stock price target?
Price Target
8.87
EUR
According to Wall Street analysts, the average 1-year price target for AT2 is 8.87 EUR with a low forecast of 3.76 EUR and a high forecast of 17.61 EUR.
What is the Revenue forecast for Atara Biotherapeutics Inc?
Projected CAGR
-5%
The compound annual growth rate for Revenue over the next 8 years is -5%.
What is the Operating Income forecast for Atara Biotherapeutics Inc?
Projected CAGR
2%
The compound annual growth rate for Operating Income over the next 5 years is 2%.
What is the Net Income forecast for Atara Biotherapeutics Inc?
Projected CAGR
-2%
The compound annual growth rate for Net Income over the next 8 years is -2%.
